Endurance Wealth Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $54K | Hold |
1,000
| – | – | 0.01% | 329 |
|
|
2023
Q1 | $50K | Hold |
1,000
| – | – | 0.01% | 344 |
|
|
2022
Q4 | $46K | Hold |
1,000
| – | – | 0.01% | 336 |
|
|
2022
Q3 | $39K | Sell |
1,000
-250
| -20% | -$9.75K | 0.01% | 350 |
|
|
2022
Q2 | $47K | Hold |
1,250
| – | – | 0.01% | 331 |
|
|
2022
Q1 | $55K | Buy |
1,250
+1,000
| +400% | +$44K | 0.01% | 341 |
|
|
2021
Q4 | $11K | Hold |
250
| – | – | ﹤0.01% | 497 |
|
|
2021
Q3 | $11K | Hold |
250
| – | – | ﹤0.01% | 510 |
|
|
2021
Q2 | $10K | Hold |
250
| – | – | ﹤0.01% | 519 |
|
|
2021
Q1 | $10K | Hold |
250
| – | – | ﹤0.01% | 530 |
|
|
2020
Q4 | $9K | Hold |
250
| – | – | ﹤0.01% | 499 |
|
|
2020
Q3 | $10K | Hold |
250
| – | – | ﹤0.01% | 468 |
|
|
2020
Q2 | $9K | Hold |
250
| – | – | ﹤0.01% | 468 |
|
|
2020
Q1 | $8K | Hold |
250
| – | – | ﹤0.01% | 444 |
|
|
2019
Q4 | $11K | Hold |
250
| – | – | ﹤0.01% | 413 |
|
|
2019
Q3 | $10K | Buy |
+250
| New | +$10K | ﹤0.01% | 418 |
|